Literature DB >> 26014037

TGF-β downregulates KLRG1 expression in mouse and human CD8(+) T cells.

Sabrina Schwartzkopff1,2, Sandra Woyciechowski1,2, Ulrike Aichele1, Tobias Flecken2,3,4, Nu Zhang5, Robert Thimme3, Hanspeter Pircher1.   

Abstract

The inhibitory receptor killer cell lectin-like receptor G1 (KLRG1) and the integrin αE (CD103) are expressed by CD8(+) T cells and both are specific for E-cadherin. However, KLRG1 ligation by E-cadherin inhibits effector T-cell function, whereas binding of CD103 to E-cadherin enhances cell-cell interaction and promotes target cell lysis. Here, we demonstrate that KLRG1 and CD103 expression in CD8(+) T cells from untreated and virus-infected mice are mutually exclusive. Inverse correlation of KLRG1 and CD103 expression was also found in human CD8(+) T cells-infiltrating hepatocellular carcinomas. As TGF-β is known to induce CD103 expression in CD8(+) T cells, we examined whether this cytokine also regulates KLRG1 expression. Indeed, our data further reveal that TGF-β signaling in mouse as well as in human CD8(+) T cells downregulates KLRG1 expression. This finding provides a rationale for the reciprocal expression of KLRG1 and CD103 in different CD8(+) T-cell subsets. In addition, it points to the limitation of KLRG1 as a marker for terminally differentiated CD8(+) T cells if lymphocytes from tissues expressing high levels of TGF-β are analyzed.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  E-cadherin. CD8+ T cell; Killer cell lectin-like receptor G1; TGF-β; αE (CD103)

Mesh:

Substances:

Year:  2015        PMID: 26014037     DOI: 10.1002/eji.201545634

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Transforming growth factor-β signaling is constantly shaping memory T-cell population.

Authors:  Chaoyu Ma; Nu Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

2.  Sensing of ATP via the Purinergic Receptor P2RX7 Promotes CD8+ Trm Cell Generation by Enhancing Their Sensitivity to the Cytokine TGF-β.

Authors:  Henrique Borges da Silva; Changwei Peng; Haiguang Wang; Kelsey M Wanhainen; Chaoyu Ma; Sharon Lopez; Alexander Khoruts; Nu Zhang; Stephen C Jameson
Journal:  Immunity       Date:  2020-07-07       Impact factor: 31.745

3.  Human Vδ2 T cells are a major source of interleukin-9.

Authors:  Christian Peters; Robert Häsler; Daniela Wesch; Dieter Kabelitz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

4.  TGF-β enhances the cytotoxic activity of Vδ2 T cells.

Authors:  Christian Peters; Annika Meyer; Léonce Kouakanou; Julia Feder; Tim Schricker; Marcus Lettau; Ottmar Janssen; Daniela Wesch; Dieter Kabelitz
Journal:  Oncoimmunology       Date:  2018-09-26       Impact factor: 8.110

Review 5.  Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders.

Authors:  Ling Chen; Zhu Shen
Journal:  Cell Mol Immunol       Date:  2019-10-08       Impact factor: 11.530

Review 6.  TGF-β: Many Paths to CD103+ CD8 T Cell Residency.

Authors:  Zhijuan Qiu; Timothy H Chu; Brian S Sheridan
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

7.  Combination GITR targeting/PD-1 blockade with vaccination drives robust antigen-specific antitumor immunity.

Authors:  Daniel O Villarreal; Diana Chin; Melissa A Smith; Leopoldo L Luistro; Linda A Snyder
Journal:  Oncotarget       Date:  2017-06-13

8.  Gag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP Study.

Authors:  Josiane Warszawski; Véronique Avettand-Fenoel; Christine Rouzioux; Daniel Scott-Algara; Thomas Montange; Céline Didier; Jérôme Le Chenadec; Jean-Paul Viard; Catherine Dollfus; Stéphane Blanche; Florence Buseyne
Journal:  Open Forum Infect Dis       Date:  2016-12-07       Impact factor: 3.835

9.  Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models.

Authors:  Steven A Greenberg; Sek Won Kong; Evan Thompson; Stefano V Gulla
Journal:  Oncotarget       Date:  2019-02-15

Review 10.  Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.

Authors:  John Reiser; Arnob Banerjee
Journal:  J Immunol Res       Date:  2016-05-22       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.